Evidence map›Paper›PMID 34323360›Full record

ArticleJournal of biomedical materials research. Part A2022

Tissue response, macrophage phenotype, and intrinsic calcification induced by cardiovascular biomaterials: Can clinical regenerative potential be predicted in a rat subcutaneous implant model?

Madeline Cramer, Jordan Chang, Hongshuai Li, Aurelie Serrero, Mohammed El-Kurdi, Martijn Cox, Frederick J Schoen, Stephen F Badylak

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Madeline CramerDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-8829-1468
Jordan ChangMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Hongshuai LiMusculoskeletal Growth and Regeneration Laboratory, Department of Orthopedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-9793-0540
Aurelie SerreroXeltis BV, Eindhoven, The Netherlands.
Mohammed El-KurdiXeltis BV, Eindhoven, The Netherlands.
Martijn CoxXeltis BV, Eindhoven, The Netherlands.ORCID 0000-0002-4165-7207
Frederick J SchoenDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Stephen F BadylakDepartment of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-3555-0689
University of Pittsburgh · USXpand Biotechnology (Netherlands) · NLBrigham and Women's Hospital · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 1988 to 2026
$158.0M
Cardiovascular Bioengineering Training ProgramT32HL076124 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SANJEEV G SHROFF · 2005 to 2026
$7.0M
Targeting Nitrate-Nitrite-NO pathway for Ameliorating Muscle and Bone Comorbidities in Duchenne Muscular DystrophyR01AR076357 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LI, HONGSHUAI · 2020 to 2024
$1.6M
Role of ECM-associated IL-33 in Functional Remodeling After Myocardial InfarctionF31HL151083 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CRAMER, MADELINE · 2020 to 2021
$72k
NCI NIH HHS P30 CA047904NHLBI NIH HHS F31 HL151083NHLBI NIH HHS T32 HL076124NIAMS NIH HHS R01 AR076357
6 · The paper itself

Abstract

The host immune response to an implanted biomaterial, particularly the phenotype of infiltrating macrophages, is a key determinant of biocompatibility and downstream remodeling outcome. The present study used a subcutaneous rat model to compare the tissue response, including macrophage phenotype, remodeling potential, and calcification propensity of a biologic scaffold composed of glutaraldehyde-fixed bovine pericardium (GF-BP), the standard of care for heart valve replacement, with those of an electrospun polycarbonate-based supramolecular polymer scaffold (ePC-UPy), urinary bladder extracellular matrix (UBM-ECM), and a polypropylene mesh (PP). The ePC-UPy and UBM-ECM materials induced infiltration of mononuclear cells throughout the thickness of the scaffold within 2 days and neovascularization at 14 days. GF-BP and PP elicited a balance of pro-inflammatory (M1-like) and anti-inflammatory (M2-like) macrophages, while UBM-ECM and ePC-UPy supported a dominant M2-like macrophage phenotype at all timepoints. Relative to GF-BP, ePC-UPy was markedly less susceptible to calcification for the 180 day duration of the study. UBM-ECM induced an archetypical constructive remodeling response dominated by M2-like macrophages and the PP caused a typical foreign body reaction dominated by M1-like macrophages. The results of this study highlight the divergent macrophage and host remodeling response to biomaterials with distinct physical and chemical properties and suggest that the rat subcutaneous implantation model can be used to predict in vivo biocompatibility and regenerative potential for clinical application of cardiovascular biomaterials.

Indexed as

Extracellular MatrixMacrophagesAnimalsBiocompatible MaterialsCattleForeign-Body ReactionPhenotypeRatsTissue ScaffoldsBiocompatible Materialsbovine pericardiumendogenous tissue restorationhost responsemacrophage phenotypesupramolecular polymer

Identifiers

PMID34323360
PMCPMC8678182
OpenAlexW3186342153

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.